Actinium Pharmaceuticals
ATNM
ATNM
30 hedge funds and large institutions have $5.02M invested in Actinium Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
40% less capital invested
Capital invested by funds: $8.43M → $5.02M (-$3.41M)
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$100K | |
| 2 | +$85K | |
| 3 | +$42.9K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$18.8K |
| 5 |
Barclays
London,
United Kingdom
|
+$13K |
Top Sellers
| 1 | -$450K | |
| 2 | -$119K | |
| 3 | -$83.1K | |
| 4 |
Morgan Stanley
New York
|
-$36.4K |
| 5 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$14K |